David Stroman Insider Profile

4 Followers
David Stroman, SVP, Ophthalmic Product Devt. at NovaBay Pharma, holds 23.00K shares in NovaBay Pharma (Ticker: NBY). Most recently, David Stroman Bought $10,000 shares of NovaBay Pharma on Dec 15, 2014 for an estimated value of 6.60K.
tipranks
David Stroman

David Stroman
NovaBay Pharma (NBY)
SVP, Ophthalmic Product Devt.

Not Ranked
David Stroman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14K
100.00%
A breakdown of David Stroman's holdings

Insider Roles

NovaBay Pharma
(NBY)
SVP, Ophthalmic Product Devt.
Roles that David Stroman holds in companies

Most Profitable Insider Trade

Stock:
NovaBay Pharma
(NBY)
Rating:Informative Buy
Date:Dec 15, 2014 - Dec 15, 2015
Return:-88.50%
The most profitable trade made by David Stroman

David Stroman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NovaBay Pharma
Dec 15, 2014
SVP, Ophthalmic Product Devt.
Informative Buy
6.60K
$14.14K
Success Rate for
NBY
0 out of 1 profitable transactions on
NBY
0%
Average Return for
NBY
Average return per transaction on
NBY
-88.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 10, 2012
Informative Buy
$12.40K
-
$1.24
Dec 15, 2014
Informative Buy
$6.60K
-
$0.66
-88.50%
List of latest transactions for each holding click on a transaction to see David Stroman's performance on stock

David Stroman insider profile FAQ

What is the percentage of profitable transactions made by David Stroman?
The percentage of profitable transactions made by David Stroman is ―.
    What is the average return per transaction made by David Stroman?
    The average return per transaction made by David Stroman is ―.
      What stocks does David Stroman hold?
      David Stroman holds: NBY stocks.
        What was David Stroman’s latest transaction?
        David Stroman latest transaction was an Informative Buy of $6.60K.
          What was David Stroman's most profitable transaction?
          David Stroman’s most profitable transaction was an Informative Buy of NBY stock on December 15, 2014. The return on the trade was -88.50%.
            What is David Stroman's role in NovaBay Pharma?
            David Stroman's role in NovaBay Pharma is SVP, Ophthalmic Product Devt..
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.